Abstract
N-Alkyl and N,N-dialkyl derivatives of 2-amino-2-deoxy-d-glucitol-6P (ADGP) were synthesized and found to inhibit growth of human pathogenic fungi (MICs in the 0.08-0.625mgmL(-1) range for the most active compounds). It was thus shown that N-alkylation of ADGP provides novel inhibitors of a fungal enzyme, glucosamine-6P synthase, exhibiting higher antifungal activity than the parent compound, due to the increased lipophilicity and better uptake by fungal cells.
MeSH terms
-
Antifungal Agents / chemical synthesis*
-
Antifungal Agents / pharmacology
-
Candida albicans / drug effects
-
Candida albicans / enzymology
-
Candida albicans / growth & development
-
Drug Design
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / pharmacology
-
Glucosamine / analogs & derivatives*
-
Glucosamine / chemical synthesis
-
Glucosamine / pharmacology
-
Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) / antagonists & inhibitors
-
Humans
-
Microbial Sensitivity Tests
-
Saccharomyces cerevisiae / drug effects
-
Saccharomyces cerevisiae / growth & development
Substances
-
Antifungal Agents
-
Enzyme Inhibitors
-
2-amino-2-deoxyglucitol
-
Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)
-
Glucosamine